Well Told Grants

Federal grant recipients / California

Federal grants to Stress Therapeutics, Inc.

San Diego, California · Small businesses · UEI VLU8DHDM9JZ3

Stress Therapeutics, Inc. in San Diego, California received $3.5 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Alcohol Research Programs, with $3.2 million. In fiscal 2025 it was awarded $2.1 million.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Stress Therapeutics, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20221$257,731
FY 20231$605,405
FY 20241$605,404
FY 20253$2.1 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Stress Therapeutics, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Alcohol Research Programs 93.2733$3.2 million
Aging Research 93.8661$349,605

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services4$3.5 million

Largest awards

The 4 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Novel therapeutic for hpa hyperactivity - summary. The hypothalamic pituitary adrenal (HPA) axis is the key neuroendocrine system that controls peripheral responses to stress. While the stress response is essential for survival, it can become dysregulated. Hyperactivity of the hpa characterizes a va
ASST_NON_R44AA027971_075 on USAspending
Alcohol Research ProgramsApril 28, 2023$1.9 million
Investigational new drug (IND)-enabling study for a new therapeutic for alcohol use disorder (AUD) - summary. While the stress response is essential for survival, it can become dysregulated. Overactivation of the hypothalamic-pituitary-adrenal (HPA) axis plays a mechanistic role in the pathophysiolo
ASST_NON_U43AA032129_075 on USAspending
Alcohol Research ProgramsMay 15, 2025$999,393
Lead optimization of a therapeutic candidate for alzheimer’s disease - summary. Overactivation of the hypothalamic-pituitary-adrenal (HPA) axis occurs in alzheimer's disease (AD) and dysregulation of the stress system plays a mechanistic role in the pathophysiology of ad progression. This phase i sb
ASST_NON_R43AG090243_075 on USAspending
Aging ResearchMay 30, 2025$349,605
Lead optimization of therapeutic candidates for alcohol use disorder (AUD) - summary. This sbir phase i proposal will set the groundwork for the clinical development of a first-in-class treatment for the long-term management of chronic hyperactivity of the hypothalamic pituitary adrenal axis (HPA) f
ASST_NON_R43AA030229_075 on USAspending
Alcohol Research ProgramsAugust 25, 2022$257,731

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Stress Therapeutics, Inc. get?

$3.5 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Stress Therapeutics, Inc. the most?

The Department of Health and Human Services, with $3.5 million in 4 awards.

What is Stress Therapeutics, Inc.'s largest federal grant?

$1.9 million under Alcohol Research Programs, with its first action in the period on April 28, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Stress Therapeutics, Inc.?

Its largest are Alcohol Research Programs and Aging Research.

Other grant recipients in San Diego

Largest federal grant recipients in California · Federal grants in California